Sartorius Aktiengesellschaft (ETR:SRT3)
221.00
-0.70 (-0.32%)
Mar 28, 2025, 5:35 PM CET
ETR:SRT3 Revenue
In the year 2024, Sartorius Aktiengesellschaft had annual revenue of 3.38B EUR, down -0.44%. Sartorius Aktiengesellschaft had revenue of 906.80M in the quarter ending December 31, 2024, with 6.71% growth.
Revenue
3.38B
Revenue Growth
-0.44%
P/S Ratio
4.51
Revenue / Employee
256.56K
Employees
13,528
Market Cap
13.70B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.38B | -15.00M | -0.44% |
Dec 31, 2023 | 3.40B | -779.00M | -18.66% |
Dec 31, 2022 | 4.17B | 725.50M | 21.03% |
Dec 31, 2021 | 3.45B | 1.11B | 47.68% |
Dec 31, 2020 | 2.34B | 508.69M | 27.84% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSartorius Aktiengesellschaft News
- 5 weeks ago - EQS-News: Sartorius releases Annual Report for 2024 - Wallstreet:Online
- 7 weeks ago - EQS-News: The Supervisory Board of Sartorius AG proposes a dividend of 0.74 euros per preference share - Wallstreet:Online
- 2 months ago - Sartorius Aktiengesellschaft (SARTF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Sartorius lifts U.S. peers after 2024 results - Seeking Alpha
- 2 months ago - Sartorius Aktiengesellschaft Non-GAAP EPS of €4.05, revenue of €3.38B; initiates FY25 soft outlook - Seeking Alpha
- 2 months ago - Sartorius Vz. Surges in Q4, Hits 2024 Targets with Positive Momentum - Wallstreet:Online
- 2 months ago - EQS-News: Sartorius closes fiscal 2024 with very good fourth quarter and positive trend; full-year guidance achieved - Wallstreet:Online
- 3 months ago - Danaher, Cryoport, Sartorius win Buy as Guggenheim expands bioprocessing coverage - Seeking Alpha